Triglyceride metabolism in bone tissue is associated with osteoblast and osteoclast differentiation: A gene expression study

Journal of Bone and Mineral Metabolism

Volumn 31, Issue 5, 2013, Pages 512-519

  Dragojevič, Jana ^a   Zupan, Janja ^a   Haring, Gregor ^a   Herman, Simon ^b   Komadina, Radko ^c   Marc, Janja ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^c General and Teaching Hospital ^*  (Slovenia)

Author keywords

Bone tissue; Free fatty acid; Lipogenesis; Lipolysis

Indexed keywords

ADIPONECTIN; FATTY ACID; FATTY ACID SYNTHASE; HORMONE SENSITIVE LIPASE; LIPOPROTEIN LIPASE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TRANSCRIPTION FACTOR RUNX2; TRIACYLGLYCEROL;

AGED; ARTICLE; BONE CHARACTERISTICS AND FUNCTIONS; BONE DENSITY; BONE TISSUE; CELL DIFFERENTIATION; CONTROLLED STUDY; FATTY ACID TRANSPORT; FEMALE; FRAGILITY FRACTURE; GENE EXPRESSION; HIP ARTHROPLASTY; HIP OSTEOARTHRITIS; HUMAN; HUMAN TISSUE; LIPID METABOLISM; LIPOGENESIS; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOBLASTOGENESIS; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOPOROSIS; PRIORITY JOURNAL;

AGED; BONE AND BONES; FEMALE; HUMANS; MALE; OSTEOARTHRITIS; OSTEOBLASTS; OSTEOCLASTS; OSTEOPOROSIS; TRIGLYCERIDES;

EID: 84885430698     PISSN: 09148779     EISSN: 14355604     Source Type: Journal    
DOI: 10.1007/s00774-013-0445-x     Document Type: Article

References (32)

1. Shen WJ, Liu LF, Patel S, Kraemer FB (2011) Hormone-sensitive lipase-knockout mice maintain high bone density during aging. FASEB J 25:2722-2730
2. Krings A, Rahman S, Huang S, Lu Y, Czernik PJ, Lecka-Czernik B (2011) Bone marrow fat has brown adipose tissue characteristics, which are attenuated with aging and diabetes. Bone 50:546-552
3. Wang H, Eckel RH (2009) Lipoprotein lipase: from gene to obesity. Am J Physiol Endocrinol Metab 297:E271-E288
4. Lass A, Zimmermann R, Oberer M, Zechner R (2011) Lipolysis: a highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores. Prog Lipid Res 50:14-27
5. Liu H, Liu JY, Wu X, Zhang JT (2010) Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker. Int J Biochem Mol Biol 1:69-89
6. Garbarino J, Sturley SL (2009) Saturated with fat: new perspectives on lipotoxicity. Curr Opin Clin Nutr Metab Care 12:110-116
7. Maurin A, Chavassieux P, Frappart L, Delmas P, Serre C, Meunier P (2000) Influence of mature adipocytes on osteoblast proliferation in human primary cocultures. Bone 26:485-489
8. Maurin A, Chavassieux P, Vericel E, Meunier P (2002) Role of polyunsaturated fatty acids in the inhibitory effect of human adipocytes on osteoblastic proliferation. Bone 31:260-266
9. Elbaz A, Wu X, Rivas D, Gimble J, Duque G (2009) Inhibition of fatty acid biosynthesis prevents adipocyte lipotoxicity on human osteoblasts in vitro. J Cell Mol Med 14:982-991
10. Cornish J, MacGibbon A, Lin J, Watson M, Callon K, Tong P, Dunford J, van der Does Y, Williams G, Grey A, Naot D, Reid I (2008) Modulation of osteoclastogenesis by fatty acids. Endocrinology 149:5688-5695
11. Oh SR, Sul OJ, Kim YY, Kim HJ, Yu R, Suh JH, Choi HS (2010) Saturated fatty acids enhance osteoclast survival. J Lipid Res 51:892-899
12. Ahima RS, Flier JS (2000) Adipose tissue as an endocrine organ. Trends Endocrinol Metab 11:327-332
13. Berner H, Lyngstadaas S, Spahr A, Monjo M, Thommesen L, Drevon C, Syversen U, Reseland J (2004) Adiponectin and its receptors are expressed in bone-forming cells. Bone 35:842-849
14. Shinoda Y, Yamaguchi M, Ogata N, Akune T, Kubota N, Yamauchi T, Terauchi Y, Kadowaki T, Takeuchi Y, Fukumoto S, Ikeda T, Hoshi K, Chung UI, Nakamura K, Kawaguchi H (2006) Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways. J Cell Biochem 99:196-208
15. Luo X, Guo L, Yuan L, Xie H, Zhou H, Wu X, Liao E (2005) Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp Cell Res 309:99-109
16. Oshima K, Nampei A, Matsuda M, Iwaki M, Fukuhara A, Hashimoto J, Yoshikawa H, Shimomura I (2005) Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem Biophys Res Commun 331:520-526
17. Yamaguchi N, Kukita T, Li YJ, Kamio N, Fukumoto S, Nonaka K, Ninomiya Y, Hanazawa S, Yamashita Y (2008) Adiponectin inhibits induction of TNF-alpha/RANKL-stimulated NFATc1 via the AMPK signaling. FEBS Lett 582:451-456
18. Williams G, Wang Y, Callon K, Watson M, Lin J, Lam J, Costa J, Orpe A, Broom N, Naot D, Reid I, Cornish J (2009) In vitro and in vivo effects of adiponectin on bone. Endocrinology 150:3603-3610
19. Tu Q, Zhang J, Dong LQ, Saunders E, Luo E, Tang J, Chen J (2011) Adiponectin inhibits osteoclastogenesis and bone resorption via APPL1-mediated suppression of Akt1. J Biol Chem 286:12542-12553
20. Luo X, Guo L, Xie H, Yuan L, Wu X, Zhou H, Liao E (2006) Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Miner Res 21:1648-1656
21. Biver E, Salliot C, Combescure C, Gossec L, Hardouin P, Legroux-Gerot I, Cortet B (2011) Influence of adipokines and ghrelin on bone mineral density and fracture risk: a systematic review and meta-analysis. J Clin Endocrinol Metab 96:2703-2713
22. Barbour KE, Zmuda JM, Boudreau R, Strotmeyer ES, Horwitz MJ, Evans RW, Kanaya AM, Harris TB, Bauer DC, Cauley JA (2011) Adipokines and the risk of fracture in older adults. J Bone Miner Res 26:1568-1576
23. Dequeker J, Boonen S, Aerssens J, Westhovens R (1996) Inverse relationship osteoarthritis-osteoporosis: what is the evidence? What are the consequences? Br J Rheumatol 35:813-818
24. Vestergaard P, Rejnmark L, Mosekilde L (2009) Osteoarthritis and risk of fractures. Calcif Tissue Int 84:249-256
25. Dragojevic J, Logar DB, Komadina R, Marc J (2011) Osteoblastogenesis and adipogenesis are higher in osteoarthritic than in osteoporotic bone tissue. Arch Med Res 42:392-397
26. Arvidsson S, Kwasniewski M, Riano-Pachon DM, Mueller-Roeber B (2008) Quantprime: a flexible tool for reliable high-throughput primer design for quantitative pcr. BMC Bioinf 9:465
27. Chang MK, Raggatt LJ, Alexander KA, Kuliwaba JS, Fazzalari NL, Schroder K, Maylin ER, Ripoll VM, Hume DA, Pettit AR (2008) Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo. J Immunol 181:1232-1244
28. Marie P (2008) Transcription factors controlling osteoblastogenesis. Arch Biochem Biophys 473:98-105
29. Boyce BF, Xing L (2008) Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys 473:139-146
30. Fazzalari NL, Kuliwaba JS, Atkins GJ, Forwood MR, Findlay DM (2001) The ratio of messenger rna levels of receptor activator of nuclear factor kappab ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis. J Bone Miner Res 16:1015-1027
31. Tsangari H, Findlay DM, Kuliwaba JS, Atkins GJ, Fazzalari NL (2004) Increased expression of IL-6 and RANK mRNA in human trabecular bone from fragility fracture of the femoral neck. Bone 35:334-342
32. Abdallah BM, Stilgren LS, Nissen N, Kassem M, Jorgensen HR, Abrahamsen B (2005) Increased RANKL/OPG mRNA ratio in iliac bone biopsies from women with hip fractures. Calcif Tissue Int 76:90-97